The Impact of Two-Invoice System on Pharmaceutical Manufacturers’ Selling Expenses in China: A Difference-in-Differences Approach

A perennial question for the pharmaceutical industry has been excessive drug prices. To alleviate patients’ burden of expensive medical bills and increase the affordability of medicines, China adopted the Two-Invoice System (TIS) in drug procurement for public medical institutions in 2017. In this p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Yi, Hu, Yuanyuan, Chen, Shouming, Qiu, Fangjun, Rabeeu, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999028/
https://www.ncbi.nlm.nih.gov/pubmed/35410081
http://dx.doi.org/10.3390/ijerph19074400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999028/
https://www.ncbi.nlm.nih.gov/pubmed/35410081
http://dx.doi.org/10.3390/ijerph19074400

Ejemplares similares